Seikagaku’s Pain Drug May Need More Tailored Indication, REMS For Approval

 
• By Sarah Karlin-Smith
  
older woman cringing with lower back, leg pain
The FDA may narrow the patient population and limit treatment sites for Seikagaku's leg pain drug. (Shutterstock)

More from US Advisory Committees

More from Product Reviews